What Activation Actually Requires

Part of Clinical Trial Assistant (CTA) Training: Site Activation.

About 4 minutes. Free, in your language, no account needed.

Why this matters

Site activation is the moment a site is permitted to begin. Getting it wrong in either direction is costly: activate late and the study loses enrollment it will not recover, activate early and every participant screened is screened without authority.

Activation is a decision with evidence behind it, not a date in a plan.

The gate, stated plainly

A site may be activated when four things are simultaneously true and evidenced.

Approval exists from the ethics committee and, where the jurisdiction requires it, the regulatory authority, naming the document versions the site will actually use.

Agreements are executed, meaning the clinical trial agreement and financial agreement are signed by people with authority to bind their institutions, not initialled drafts.

The team is qualified and delegated, with CVs, training records and a signed delegation log that predates any delegated task.

The site can actually run the study: product handling and storage arranged, laboratory ready with current certification and ranges, equipment calibrated, and the systems the study depends on accessible to the people who need them.

If any one is missing, the site is not activated regardless of what the plan says.

The activation crunch

Activation crunches happen because the four conditions are worked in parallel by different people and converge late. The pattern is always the same: everything is nearly ready, one item is outstanding, and pressure arrives to start anyway.

Your job in that moment is to be precise about which item is outstanding and what it blocks. "We are waiting on the countersigned agreement" is actionable. "We are not quite ready" invites someone to decide you are being cautious.

The question to ask out loud is: what happens to the first participant if we start without this. If the answer is nothing, it is an administrative item and can follow. If the answer involves consent, eligibility, product or approval, it is a gate and it cannot.

Greenlight is a record, not a message

Activation should produce a dated record saying who authorized the site to begin, on what evidence, and from when. A verbal go-ahead in a call leaves the study unable to answer when the site was permitted to start, and that is the first question at inspection if anything went wrong early.

In practice

A site in Warsaw is scheduled to activate on the 19th. On the 16th the position is: ethics approval received, regulatory notification complete, delegation log signed, laboratory ready, product handling arranged, and the clinical trial agreement signed by the site but not yet countersigned by the sponsor's legal team, who are waiting on one indemnity clause.

The project manager asks whether you can activate on the 19th and countersign that week.

The answer is no, and the reason is worth being able to state. An executed agreement is what allows the site to be paid and, more importantly, establishes indemnity and the allocation of liability before a participant is exposed to an investigational product. A site operating without one is a site whose institution has not agreed the terms under which its patients take risk.

That is different from, say, a missing insurance certificate copy, which is an evidence gap rather than a gate.

Saying no usefully

"We cannot activate on the 19th" is unhelpful on its own. What the study needs is: the single outstanding item, who holds it, what unblocks it, and what date becomes achievable.

"Activation is blocked on the countersigned CTA, which is with sponsor legal pending the indemnity clause. If that closes by Wednesday the 18th we hold the 19th. If it closes Thursday we activate Monday the 23rd. Everything else at this site is complete."

That message gets escalated to the person who can move legal, which is the actual outcome you want. A cautious message gets you overruled; a specific one gets the blocker cleared.

Key takeaways